Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for VERU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 37.03M
March 31, 2026 43.08M
December 31, 2025 47.57M
September 30, 2025 29.84M
June 30, 2025 27.33M
March 31, 2025 32.67M
December 31, 2024 39.83M
September 30, 2024 60.81M
June 30, 2024 64.63M
March 31, 2024 71.80M
December 31, 2023 80.57M
September 30, 2023 50.47M
June 30, 2023 62.53M
March 31, 2023 70.25M
December 31, 2022 103.78M
September 30, 2022 135.36M
June 30, 2022 160.58M
March 31, 2022 172.83M
December 31, 2021 172.16M
September 30, 2021 178.15M
June 30, 2021 180.07M
March 31, 2021 181.15M
December 31, 2020 72.79M
September 30, 2020 51.54M
June 30, 2020 65.19M
Date Value
March 31, 2020 55.88M
December 31, 2019 54.54M
September 30, 2019 53.63M
June 30, 2019 53.84M
March 31, 2019 51.01M
December 31, 2018 52.34M
September 30, 2018 48.45M
June 30, 2018 53.47M
March 31, 2018 58.20M
December 31, 2017 51.05M
September 30, 2017 55.34M
June 30, 2017 57.43M
March 31, 2017 57.18M
December 31, 2016 60.56M
September 30, 2016 38.62M
June 30, 2016 40.62M
March 31, 2016 39.89M
December 31, 2015 39.32M
September 30, 2015 37.47M
June 30, 2015 37.16M
March 31, 2015 35.89M
December 31, 2014 32.91M
September 30, 2014 31.67M
June 30, 2014 32.68M
March 31, 2014 33.21M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Johnson & Johnson 201.06B
Eli Lilly & Co. 142.28B
Lexicon Pharmaceuticals, Inc. 250.06M

Total Assets (Quarterly) Related Metrics